Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 3
1972 1
1973 1
1996 2
1997 1
2004 1
2005 1
2006 1
2007 1
2008 2
2009 2
2010 5
2011 5
2012 9
2013 9
2014 8
2015 13
2016 13
2017 19
2018 15
2019 11
2020 17
2021 25
2022 19
Text availability
Article attribute
Article type
Publication date

Search Results

153 results
Results by year
Filters applied: . Clear all
Page 1
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.
Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, van den Berg B, Doets AY, Leonhard SE, Verboon C, Huizinga R, Drenthen J, Arends S, Budde IK, Kleyweg RP, Kuitwaard K, van der Meulen MFG, Samijn JPA, Vermeij FH, Kuks JBM, van Dijk GW, Wirtz PW, Eftimov F, van der Kooi AJ, Garssen MPJ, Gijsbers CJ, de Rijk MC, Visser LH, Blom RJ, Linssen WHJP, van der Kooi EL, Verschuuren JJGM, van Koningsveld R, Dieks RJG, Gilhuis HJ, Jellema K, van der Ree TC, Bienfait HME, Faber CG, Lovenich H, van Engelen BGM, Groen RJ, Merkies ISJ, van Oosten BW, van der Pol WL, van der Meulen WDM, Badrising UA, Stevens M, Breukelman AJ, Zwetsloot CP, van der Graaff MM, Wohlgemuth M, Hughes RAC, Cornblath DR, van Doorn PA; Dutch GBS Study Group. Walgaard C, et al. Among authors: arends s. Lancet Neurol. 2021 Apr;20(4):275-283. doi: 10.1016/S1474-4422(20)30494-4. Epub 2021 Mar 17. Lancet Neurol. 2021. PMID: 33743237 Clinical Trial.
Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.
Luijten LWG, Leonhard SE, van der Eijk AA, Doets AY, Appeltshauser L, Arends S, Attarian S, Benedetti L, Briani C, Casasnovas C, Castellani F, Dardiotis E, Echaniz-Laguna A, Garssen MPJ, Harbo T, Huizinga R, Humm AM, Jellema K, van der Kooi AJ, Kuitwaard K, Kuntzer T, Kusunoki S, Lascano AM, Martinez-Hernandez E, Rinaldi S, Samijn JPA, Scheidegger O, Tsouni P, Vicino A, Visser LH, Walgaard C, Wang Y, Wirtz PW, Ripellino P, Jacobs BC; IGOS consortium. Luijten LWG, et al. Among authors: arends s. Brain. 2021 Dec 16;144(11):3392-3404. doi: 10.1093/brain/awab279. Brain. 2021. PMID: 34553216 Free PMC article.
Ten years of the ESSDAI: is it fit for purpose?
de Wolff L, Arends S, van Nimwegen JF, Bootsma H. de Wolff L, et al. Among authors: arends s. Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):283-290. Epub 2020 Oct 23. Clin Exp Rheumatol. 2020. PMID: 33095151 Free article. Review.
CD27-CD38lowCD21low B-Cells Are Increased in Axial Spondyloarthritis.
Wilbrink R, Spoorenberg A, Arends S, van der Geest KSM, Brouwer E, Bootsma H, Kroese FGM, Verstappen GM. Wilbrink R, et al. Among authors: arends s. Front Immunol. 2021 Jun 8;12:686273. doi: 10.3389/fimmu.2021.686273. eCollection 2021. Front Immunol. 2021. PMID: 34168654 Free PMC article.
Differences in presentation between paediatric- and adult-onset primary Sjögren's syndrome patients.
Legger GE, Erdtsieck MB, de Wolff L, Stel AJ, Los LI, Verstappen GM, Spijkervet FKL, Vissink A, van der Vegt B, Kroese FGM, Armbrust W, Arends S, Bootsma H. Legger GE, et al. Among authors: arends s. Clin Exp Rheumatol. 2021 Nov-Dec;39 Suppl 133(6):85-92. doi: 10.55563/clinexprheumatol/vxe6h0. Epub 2021 Nov 10. Clin Exp Rheumatol. 2021. PMID: 34796855 Free article.
Fracture Risk Reduction by Bisphosphonates in Mastocytosis?
Onnes MC, van Doormaal JJ, van der Veer E, Versluijs JB, Arends S, Oude Elberink HNG. Onnes MC, et al. Among authors: arends s. J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3557-3564. doi: 10.1016/j.jaip.2020.06.054. Epub 2020 Jul 13. J Allergy Clin Immunol Pract. 2020. PMID: 32673882
153 results